feedback

Course Director

Thomas M. File, Jr., MD, MSc, MACP, FIDSA, FCCP
Thomas M. File, Jr., MD, MSc, MACP, FIDSA, FCCP

Summa Health
Akron, Ohio
Northeast Ohio Medical University
Rootstown, Ohio

Accredited by

University of Florida College of Medicine

Activity Details

Credit Types: CME / CE / CPE
Credit Amount: 0.75 CME/CPE / 1.0 CE
Release Date: 2018-Feb-27
Expiration Date: 2019-Feb-26
Estimated Time for Completion: 45 minutes
Registration Required: No
Cost: Free of charge

Activity Description and Educational Objectives

Pneumococcal infections—including pneumonia and invasive disease such as bacteremia and meningitis—remain an important source of morbidity and mortality in adults, especially among older adults and those with certain conditions, including immunocompromising conditions and asplenia. Currently, two inactivated vaccines are available that elicit antibody responses to the most common pneumococcal serotypes that infect humans: PPSV23 (pneumococcal polysaccharide vaccine-23) and PCV13 (pneumococcal conjugate vaccine-13). Despite widely publicized recommendations and the fact that pneumococcal vaccines are cost effective, vaccination rates among adults remain suboptimal. It is clear that barriers to successful adult vaccination exist on many levels, including healthcare providers, healthcare delivery systems, and patients. In this activity, an expert in infectious diseases assesses the role of currently available vaccines in protecting against pneumococcal disease and offers practical guidance on improving pneumococcal vaccination rates among adults in accordance with current recommendations.

Upon completion of this activity, participants will be able to:
  • Discuss the morbidity and mortality of pneumococcal disease in at-risk adults
  • Identify immunocompromising and chronic conditions that increase patients' risk of pneumococcal disease
  • Describe the immunogenicity, efficacy and safety of available pneumococcal vaccines
  • Apply current Advisory Committee on Immunization Practices (ACIP) recommendations for pneumococcal vaccination in older and high-risk adults, recognizing the importance of optimal vaccine timing
  • Improve pneumococcal vaccination coverage rates by implementing practice- and system-based tools to identify and immunize older and high-risk adults

Target Audience

This activity has been designed to meet the educational needs of primary care physicians, pharmacists, nurses, and other clinicians involved in the management of patients at risk for pneumococcal disease.

Nursing Education Purpose Statement

The purpose of this activity is to improve knowledge and competence of nurses concerning the prevention of pneumococcal disease through vaccination.

Requirements for Successful Completion

In order to receive credit, participants must view the activity and complete the post-test and evaluation form. A score of 80% or higher is needed to obtain CME credit and 70% or higher to obtain CE/CPE credit. There are no pre-requisites and there is no fee to participate in this activity or to receive CME/CE/CPE credit. Statements of Credit are awarded upon successful completion of the post-test and evaluation form.

Media: Enduring Material
Release and Expiration Dates: February 27, 2018 - February 26, 2019
Time to Complete: 45 minutes

Faculty & Disclosure / Conflict of Interest Policy

In accordance with ACCME requirements, the University of Florida College of Medicine has a conflict of interest policy that requires faculty to disclose relevant financial relationships related to the content of their presentations/materials. Any potential conflicts are resolved so that presentations are evidence-based and scientifically balanced.

Course Director and Moderator

Thomas M. File, Jr., MD, MSc, MACP, FIDSA, FCCP
Chair, Infectious Disease Division
Summa Health
Akron, Ohio
Professor, Chair of Infectious Disease Section, and Master Teacher
Northeast Ohio Medical University
Rootstown, Ohio

Thomas M. File, Jr., MD, MSc, MACP, FIDSA, FCCP, has a financial interest/relationship or affiliation in the form of:
Consultant for Allergan; BioMérieux, Inc.; Curetis USA Inc.; GlaxoSmithKline; Merck & Co., Inc.; Motif Bio; Paratek; Pfizer Inc.; Shionogi Inc.; and The Medicines Company.
Advisory Board for Allergan; BioMérieux, Inc.; Curetis USA Inc.; GlaxoSmithKline; Merck & Co., Inc.; Motif Bio; Paratek; Pfizer Inc.; Shionogi Inc.; and The Medicines Company.
Thomas M. File, Jr., MD, MSc, MACP, FIDSA, FCCP, does not intend to discuss any non-FDA-approved or investigational use of any products/devices.

CME Reviewer

Eric I. Rosenberg, MD, MSPH, FACP
University of Florida College of Medicine
Gainesville, Florida

Eric I. Rosenberg, MD, MSPH, FACP, has no financial interests/relationships or affiliations in relation to this activity.

Nurse Reviewer

Bobbie Perrin, RN, OCN
Harrington Cancer Center
Amarillo, Texas

Bobbie Perrin, RN, OCN, has no financial interests/relationships or affiliations in relation to this activity.

CPE Reviewer

Teresa Haile, RPh, MBA
Blue Cross Blue Shield of Kansas City
Kansas City, Missouri

Teresa Haile, RPh, MBA, has no financial interests/relationships or affiliations in relation to this activity.

Medical Director

Kathryn B. Charalambous, PhD
PVI, PeerView Institute for Medical Education

Kathryn B. Charalambous, PhD, has no financial interests/relationships or affiliations in relation to this activity.

Disclaimer

The information provided at this CME/CE/CPE activity is for continuing education purposes only and is not meant to substitute for the independent medical judgment of a healthcare provider relative to diagnostic and treatment options of a specific patient’s medical condition. Recommendations for the use of particular therapeutic agents are based on the best available scientific evidence and current clinical guidelines. No bias towards or promotion for any agent discussed in this program should be inferred.

Providership, Credit & Support

Physicians

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the University of Florida College of Medicine and PVI, PeerView Institute for Medical Education. The University of Florida College of Medicine is accredited by the ACCME to provide continuing medical education for physicians.

The University of Florida College of Medicine designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nurses

Medical Learning Institute, Inc.
Provider approved by the California Board of Registered Nursing, Provider Number 15106, for 1.0 contact hour(s).

Pharmacists

ACPE The Medical Learning Institute, Inc. is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. Completion of this knowledge-based activity provides for 0.75 contact hours (0.075 CEUs) of continuing pharmacy education credit. The Universal Activity Number for this activity is 0468-9999-18-003-H01-P.

Providership

This CME/CE/CPE activity is jointly provided by University of Florida College of Medicine and PVI, PeerView Institute for Medical Education; this activity is also co-provided by Medical Learning Institute, Inc.

Support

This activity is supported by an educational grant from Merck & Co., Inc.

Disclosure of Unlabeled Use

The faculty of this educational activity may include discussions of products or devices that are not currently labeled for use by the FDA. Faculty members have been advised to disclose to the audience any reference to an unlabeled or investigational use.

No endorsement of unapproved products or uses is made or implied by coverage of these products or uses in our reports. No responsibility is taken for errors or omissions in reports. For approved prescribing information, please consult the manufacturer’s product labeling.

The materials presented here are used with the permission of the authors and/or other sources. These materials do not necessarily reflect the views of PeerView or any of its partners, providers, and/or supporters.

About This CME/CE/CPE Activity

PVI, PeerView Institute for Medical Education, the University of Florida College of Medicine, and Medical Learning Institute, Inc. are responsible for the selection of this activity’s topics, the preparation of editorial content, and the distribution of this activity. Our activities may contain references to unapproved products or uses of these products in certain jurisdictions. The preparation of PeerView activities is supported by educational grants subject to written agreements that clearly stipulate and enforce the editorial independence of PVI, the University of Florida College of Medicine, and Medical Learning Institute, Inc.

Copyright © 2000-2018, PeerView

Suggest a CME Activity

Please provide below the URL and description of an activity you would like to add to OpenCME. You are welcome to add activities as often as you like. To prevent spam or other abuse, activities are reviewed by our editorial team before appearing on OpenCME.

OpenCME for Publishers

Please use the form below if you would like to offer your website visitors high-quality CME content by adding the OpenCME Widget to one or more of your pages.

Send Email to a Colleague

To share this activity with one or more colleagues, enter their e-mail addresses below. To include a personal message, simply overwrite the suggested text below.

(So your recipient knows it's from you.)
Enter multiple recipients separated by a space.
Optionally, replace/modify in the box above the message that will be sent to your colleague(s) with a link to download this app.